TCM
TMO icon

Tributary Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Tributary Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-865
Closed -$425K – 170
2026
Q1 		$425K Sell
865
-10
-1% -$5.43K 0.04% 133
2025
Q4 		$507K Buy
+875
New +$495K 0.05% 123
2025
Q2 		– Sell
-1,045
Closed -$520K – 168
2025
Q1 		$520K Sell
1,045
-30
-3% -$16.2K 0.05% 118
2024
Q4 		$559K Sell
1,075
-235
-18% -$129K 0.04% 113
2024
Q3 		$810K Sell
1,310
-50
-4% -$29.6K 0.06% 88
2024
Q2 		$752K Sell
1,360
-55
-4% -$31.5K 0.06% 94
2024
Q1 		$822K Sell
1,415
-30
-2% -$16.8K 0.07% 92
2023
Q4 		$767K Sell
1,445
-25
-2% -$12.1K 0.06% 100
2023
Q3 		$744K Sell
1,470
-20
-1% -$10.7K 0.07% 89
2023
Q2 		$777K Sell
1,490
-15
-1% -$8.09K 0.07% 85
2023
Q1 		$867K Buy
1,505
+50
+3% +$28.2K 0.08% 80
2022
Q4 		$801K Sell
1,455
-25
-2% -$13.2K 0.08% 82
2022
Q3 		$751K Sell
1,480
-15
-1% -$8.39K 0.08% 77
2022
Q2 		$812K Sell
1,495
-45
-3% -$24.8K 0.08% 73
2022
Q1 		$910K Sell
1,540
-40
-3% -$23K 0.07% 133
2021
Q4 		$1.05M Sell
1,580
-65
-4% -$40.6K 0.08% 142
2021
Q3 		$940K Sell
1,645
-35
-2% -$19.2K 0.07% 145
2021
Q2 		$848K Sell
1,680
-30
-2% -$14.2K 0.06% 151
2021
Q1 		$780K Buy
1,710
+205
+14% +$97.8K 0.06% 154
2020
Q4 		$701K Sell
1,505
-350
-19% -$164K 0.05% 160
2020
Q3 		$819K Sell
1,855
-95
-5% -$39.2K 0.07% 146
2020
Q2 		$707K Sell
1,950
-90
-4% -$30.2K 0.06% 155
2020
Q1 		$579K Sell
2,040
-50
-2% -$15.8K 0.06% 156
2019
Q4 		$679K Sell
2,090
-400
-16% -$121K 0.05% 163
2019
Q3 		$725K Sell
2,490
-35
-1% -$10K 0.05% 158
2019
Q2 		$742K Sell
2,525
-775
-23% -$213K 0.05% 155
2019
Q1 		$903K Hold
3,300
– – 0.07% 148
2018
Q4 		$739K Hold
3,300
– – 0.07% 152
2018
Q3 		$805K Sell
3,300
-50
-1% -$11.5K 0.06% 155
2018
Q2 		$694K Sell
3,350
-250
-7% -$53.1K 0.05% 159
2018
Q1 		$743K Sell
3,600
-400
-10% -$84K 0.06% 148
2017
Q4 		$760K Sell
4,000
-200
-5% -$38.3K 0.07% 153
2017
Q3 		$795K Hold
4,200
– – 0.07% 151
2017
Q2 		$733K Sell
4,200
-200
-5% -$33.6K 0.06% 157
2017
Q1 		$676K Hold
4,400
– – 0.07% 169
2016
Q4 		$621K Hold
4,400
– – 0.07% 174
2016
Q3 		$700K Hold
4,400
– – 0.09% 171
2016
Q2 		$650K Buy
+4,400
New +$649K 0.09% 169
2014
Q1 		– Sell
-25,800
Closed -$2.87M – 184
2013
Q4 		$2.87M Hold
25,800
– – 0.57% 86
2013
Q3 		$2.38M Hold
25,800
– – 0.49% 102
2013
Q2 		$2.18M Buy
+25,800
New +$2.15M 0.36% 139

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Tributary Capital Management's TMO Position: Q2 2026 in Review

Tributary Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 865 shares — an estimated $425K sold.

Tributary Capital Management first reported a position in TMO in Q2 2013 and held it in 41 quarters. The position peaked at $2.87M in Q4 2013. 777 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Tributary Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Tributary Capital Management sold 865 Thermo Fisher Scientific shares in Q2 2026, an estimated $425K.
  • Tributary Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 41 quarters.
  • Tributary Capital Management's Thermo Fisher Scientific position peaked at $2.87M in Q4 2013.
  • 777 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Tributary Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.